March 5, 2025- Our collaboration effort on developing an “off-the-shelf” CAR-NKT cell therapy for ovarian cancer, together with UCLA Clinician Dr. Sanaz Memarzadeh, Bioinformatician Dr. Matteo Pellegrini, and Biostatistician Dr. Jin Zhou, is featured on various UCLA News. Game on! […]
February 29, 2025- Our Postdoctoral Scholar, Charlie Yan-Ruide Li, is awarded the 2025 UCLA Goodman-Luskin Microbiome Center Collaborative Research Fellowship. This fellowship is awarded to outstanding trainees and early-stage investigators exploring microbiome research. Congratulations! June 14, 2024- Our Postdoctoral Scholar, […]
May 30, 2024- Dr. Lili Yang receives a $6.3 million CIRM Partnering Opportunity for Translational Research Projects Award to translate a novel stem cell-engineered off-the-shelf CAR-NKT cell therapy for ovarian cancer into clinics. [Link][PDF] May 18, 2021- Dr. Lili Yang […]
We are currently recruiting PhD students (2 openings) and postdoctoral researchers (1 opening). Welcome to apply! [PhD Openings][Postdoc Openings]
May 11, 2021- Our off-the-shelf cell therapy technology is licensed by a Biotech startup, Appia Bio, for commercial development. The company launches with $52 million Series A financing. [Appia News][Endpoints News] August 5, 2021- Appia Bio and Kite announce collaboration […]
Our paper is published on Science Immunology, reporting the identification of monoamine oxidase A (MAO-A) as an immune checkpoint restraining antitumor T cell immunity and the repurposing of MAO inhibitor (MAOI) antidepressants for cancer immunotherapy. Congratulations to all the authors, […]
Our JEM paper reporting creatine uptake regulation of CD8 T cell immunity is featured on UCLA News and other media. [PDF][UCLA News][UC News][MedicalXpress][ScienceDaily][The Medical News][Technology Networks]
Our paper reporting creatine uptake regulation of CD8 T cell immunity is published online on the Journal of Experimental Medicine. Congratulations to all the authors, in particular to the co-first authors Stefano Di Biase & Jessie Xiaoya Ma! [Link]
Our Cell Stem Cell paper reporting HSC-engineered iNKT cell therapy is featured on the journal’s October issue for “In Translation”. [link]
Our Cell Stem Cell paper reporting HSC-engineering iNKT cell cancer therapy is featured on UCLA News and other media. [PDF][UCLA News][Medical News Today][The Stem Cell Podcast]
Next Page »
